Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$171,064
-$334,709 QoQ
Shares Held
1,354
-62.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,937
of 2,266 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Morse Asset Management, Inc holds $27,585,966 across 9 Drug Manufacturers - General names. GILD ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,610 | $11,526,523 | |
| 2 | JNJ |
Johnson & Johnson
|
26,231 | $6,661,887 | |
| 3 | ABBV |
AbbVie Inc.
|
18,441 | $4,640,493 | |
| 4 | MRK |
Merck & Co., Inc.
|
32,843 | $4,220,325 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
5,000 | $288,100 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
1,354 | $171,064 | |
| 7 | AMGN |
Amgen Inc
|
200 | $72,424 | |
| 8 | GSK |
GSK plc
|
90 | $4,717 |
All Filings in GILD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $171,064 | 1,354 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $505,773 | 3,629 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,215,126 | 9,900 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||